Company Comparison
Oryzon Genomics vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Oryzon Genomics | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Barcelona, Spain | — |
| Founded | 2000 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | — |
| Total Funding | $50M | — |
| Valuation | — | — |
What They Build
Oryzon Genomics
Spanish biopharmaceutical company developing epigenetic therapies for cancer and CNS diseases using histone deacetylase and lysine demethylase inhibitors.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Sector Overlap
Both Oryzon Genomics and 10x Genomics operate in Biotech.
Browse all Biotech companies →